title: Management of complicated facial hemangiomas with beta-blocker (propranolol) therapy.
authors.affiliation: Vancouver, British Columbia, Canada; and Detroit, Mich. From the Division of Plastic Surgery/Vascular Anomalies Clinic, British Columbia Children's Hospital and the University of British Columbia, and the Vascular Anomalies Clinic, Children's Hospital of Michigan.
authors.forename: Jugpal S
authors.initials: JS
authors.lastname: Arneja
authors.forename: Peggy N
authors.initials: PN
authors.lastname: Pappas
authors.forename: Tor A
authors.initials: TA
authors.lastname: Shwayder
authors.forename: Marc L
authors.initials: ML
authors.lastname: Cullen
authors.forename: Cristie J
authors.initials: CJ
authors.lastname: Becker
authors.forename: Fasahat H
authors.initials: FH
authors.lastname: Hamzavi
authors.forename: John D
authors.initials: JD
authors.lastname: Roarty
authors.forename: David N
authors.initials: DN
authors.lastname: Madgy
authors.forename: John D
authors.initials: JD
authors.lastname: Baker
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006391:Hemangioma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D011433:Propranolol / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol
references.citation: Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med. 1999;341:173–181.
references.citation: Arneja JS, Gosain AK. Vascular malformations. Plast Reconstr Surg. 2008;121:195e–206e.
references.citation: Beck DO, Gosain AK. The presentation and management of hemangiomas. Plast Reconstr Surg. 2009;123:181e–191e.
references.citation: Lande RG, Crawford PM, Ramsey BJ. Psychosocial impact of vascular birthmarks. Facial Plast Surg Clin North Am. 2001;9:561–567.
references.citation: Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JE, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649–2651.
references.citation: Sans V, Dumas de la Roque E, Berge J, et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics 2009;124:e423.
references.citation: Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: Case report of novel treatment. Laryngoscope 2009;119:2051–2054.
references.citation: Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol. 2009;73:1168–1172.
references.citation: Persad S, Rupp H, Jindal R, Arneja J, Dhalla NS. Modification of cardiac beta-adrenoceptor mechanisms by H2O2. Am J Physiol. 1998;274:H416–H423.
references.citation: Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: Risks and recommendations. Pediatr Dermatol. 2009;26:610–614.
references.citation: Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med. 2008;359:2846.
references.citation: Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg. 2009;17:458–459.
references.citation: Garlichs CD, Zhang H, Mügge A, Daniel WG. Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells. Eur J Clin Invest. 1999;29:12–16.
references.citation: Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Béliveau R. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res. 2009;60:438–445.
references.citation: Romana-Souza B, Nascimento AP, Monte-Alto-Costa A. Low-dose propranolol improves cutaneous wound healing of burn-injured rats. Plast Reconstr Surg. 2008;122:1690–1699.
references.citation: Arneja JS, Mulliken JB. Resection of amblyogenic periocular hemangiomas: Indications and outcomes. Plast Reconstr Surg. 2010;125:274–281.